Literature DB >> 27726779

Overview of Infections in the Immunocompromised Host.

Lesia K Dropulic1, Howard M Lederman2.   

Abstract

Understanding the components of the immune system that contribute to host defense against infection is key to recognizing infections that are more likely to occur in an immunocompromised patient. In this review, we discuss the integrated system of physical barriers and of innate and adaptive immunity that contributes to host defense. Specific defects in the components of this system that predispose to particular infections are presented. This is followed by a review of primary immunodeficiency diseases and secondary immunodeficiencies, the latter of which develop because of a specific illness or condition or are treatment-related. The effects of treatment for neoplasia, autoimmune diseases, solid organ and stem cell transplants on host defenses are reviewed and associated with susceptibility to particular infections. In conclusion, an approach to laboratory screening for a suspected immunodeficiency is presented. Knowledge of which host defects predispose to specific infections allows clinicians to prevent, diagnose, and manage infections in their immunocompromised patients most effectively.

Entities:  

Mesh:

Year:  2016        PMID: 27726779     DOI: 10.1128/microbiolspec.DMIH2-0026-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  14 in total

Review 1.  Cough in Ambulatory Immunocompromised Adults: CHEST Expert Panel Report.

Authors:  Mark J Rosen; Belinda Ireland; Mangala Narasimhan; Cynthia French; Richard S Irwin
Journal:  Chest       Date:  2017-08-19       Impact factor: 9.410

2.  Otogenic Central Skull Base Osteomyelitis With Retropharyngeal Extension: A Case Report.

Authors:  Regina Jacobo-Pinelli; Jose Alberto Guerrero-Paz; Juan Antonio Lugo-Machado; Jose Alberto Arvizu-Flores; Karen Paulina Guerrero-Paz
Journal:  Cureus       Date:  2022-03-09

3.  Staphylococcus aureus genotype variation among and within periprosthetic joint infections.

Authors:  Dongzhu Ma; Kimberly M Brothers; Patrick L Maher; Nathan J Phillips; Deborah Simonetti; Anthony William Pasculle; Anthony R Richardson; Vaughn S Cooper; Kenneth L Urish
Journal:  J Orthop Res       Date:  2021-04-02       Impact factor: 3.494

4.  Varicella-zoster virus meningitis with hypoglycorrhachia in a young immunocompetent adult without rash: A case report and literature review.

Authors:  Nikolaos Spernovasilis; Athanasia Milioni; Ioannis Gialamas; Evangelos Kokorakis; Garufallia Fanti
Journal:  IDCases       Date:  2018-04-13

5.  Pyomyositis and Infectious Myositis: A Comprehensive, Single-Center Retrospective Study.

Authors:  Christopher Radcliffe; Savanah Gisriel; Yu Si Niu; David Peaper; Santiago Delgado; Matthew Grant
Journal:  Open Forum Infect Dis       Date:  2021-03-04       Impact factor: 3.835

6.  Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

Authors:  Fabian J S van der Velden; Andrew R Gennery; Marieke Emonts
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

7.  Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales.

Authors:  Liang Chen; Xiudi Han; YanLi Li; Minghui Li
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

8.  Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.

Authors:  Kailey Hughes; Donald B Middleton; Mary Patricia Nowalk; Goundappa K Balasubramani; Emily T Martin; Manjusha Gaglani; H Keipp Talbot; Manish M Patel; Jill M Ferdinands; Richard K Zimmerman; Fernanda P Silveira
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

9.  Diagnostic value and clinical application of next-generation sequencing for infections in immunosuppressed patients with corticosteroid therapy.

Authors:  Sen Wang; Jingwen Ai; Peng Cui; Yimin Zhu; Honglong Wu; Wenhong Zhang
Journal:  Ann Transl Med       Date:  2020-03

10.  Exposition to Biological Control Agent Trichoderma stromaticum Increases the Development of Cancer in Mice Injected With Murine Melanoma.

Authors:  Uener R Dos Santos; Marliete C Costa; Gustavo J C de Freitas; Flávia S de Oliveira; Bianca R Santos; Juneo F Silva; Daniel A Santos; Adriana A M Dias; Luciana D de Carvalho; Danillo G Augusto; Jane L Dos Santos
Journal:  Front Cell Infect Microbiol       Date:  2020-05-29       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.